Carregant...

The Effect of the Targeted Recombinant Toxin DARPin-PE40 on the Dynamics of HER2-Positive Tumor Growth

The development of targeted toxins based on non-immunoglobulin targeting molecules appears to be one of the most advanced approaches in the targeted therapy of malignant tumors with a high expression of the HER2 receptor. Earlier, we showed that the targeted toxin DARPin-PE40 consisting of the HER2-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Naturae
Autors principals: Sokolova, E.A., Proshkina, G.M., Kutova, O.M., Balalaeva, I.V., Deyev, S.M.
Format: Artigo
Idioma:Inglês
Publicat: A.I. Gordeyev 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5662280/
https://ncbi.nlm.nih.gov/pubmed/29104782
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!